ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Behavioural Brain Research
Volume 166, Issue 1, January 2006, Pages 140-149
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (489 K)

Article Toolbox
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.bbr.2005.07.018    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2005 Elsevier B.V. All rights reserved.

Research report

Light/dark cycle manipulation influences mice behaviour in the elevated plus maze

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Florence Clénet, Eric Bouyon, Martine Hascoët and Michel BourinCorresponding Author Contact Information, E-mail The Corresponding Author

EA 3256 Neurobiologie de l’anxiété et de la Dépression, Faculté de Médecine, BP 53508, 1 rue Gaston Veil, 44035 Nantes Cedex 01, France


Received 19 May 2005; 
revised 21 July 2005; 
accepted 22 July 2005. 
Available online 13 September 2005.

Abstract

The sensitization of animal models of anxiety is of great importance to detect potential anxiolytic drugs. Our goal was to evaluate the influence of manipulations of the light/dark cycle on the basal anxious behaviour of mice and the efficacy of two anxiolytic treatments in the mouse elevated plus maze (EPM). Male Swiss mice were exposed to different conditions of illumination for one week prior to testing. In the first experiment of the study, we evaluated the anxiolytic effects of diazepam, at the dose of 1 mg/kg, intraperitoneally (i.p.) administered 30 min before the test. In the second experiment, we examined the effects of WAY 100635, a 5-HT1A receptor antagonist, at the doses of 0.03 and 2 mg/kg, i.p. administered 30 min before the test. The locomotor activity of control mice and the anxiolytic efficacy of diazepam in the EPM were not affected by manipulation of the light/dark cycle. Conversely, the effects of WAY 100635, which were qualitatively different from those of diazepam, seemed to be influenced by the illumination conditions imposed before the test. We can conclude that diazepam's effect, which is characterized by a strong “disinhibition”, was more robust than the 5-HT1A antagonist's effect, which was more anxioselective. Moreover, the light conditions imposed on mice before the test may be an important factor in the variability of the response to serotonergic but not to benzodiazepine treatments.

Keywords: Anxiety; Light; GABA; Serotonin; Elevated plus maze (EPM); Benzodiazepine

Article Outline

1. Introduction
2. Materials and methods
2.1. Animals
2.2. Drugs
2.3. Pharmacological tests
2.3.1. Experimental procedure
2.3.2. Measure of locomotor activity [9]
2.3.3. Elevated plus maze (EPM) [44]
2.4. Data analysis
3. Results
3.1. Actimeter test
3.1.1. Comparison of diazepam with control from each room (Student t-test)
3.1.2. Comparison across rooms (two-way ANOVA + post hoc Dunnett test)
3.2. Elevated plus maze
3.2.1. First experiment: influence of the light/dark cycle on the anxiolytic-like effects of diazepam: Comparison of diazepam with the control group in each room (Student t-test)
3.2.2. Second experiment: influence of the light/dark cycle on the anxiolytic effects of WAY 100635
3.2.2.1. Comparison of treated groups with the control group from each room (one-way ANOVA + post hoc Dunnett test)
3.2.2.2. Comparison across rooms (two-way ANOVA + post hoc Dunnett test)
4. Discussion
References




Corresponding Author Contact InformationCorresponding author. Tel.: +33 2 40 41 28 53; fax: +33 2 40 41 28 56.

Behavioural Brain Research
Volume 166, Issue 1, January 2006, Pages 140-149
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.